Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England

View ORCID ProfileAlfredo Maria Gravagnuolo, Layla Faqih, Cara Cronshaw, Jackie Wynn, Lewis Burglin, Paul Klapper, Mark Wigglesworth
doi: https://doi.org/10.1101/2021.01.14.21249386
Alfredo Maria Gravagnuolo
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alfredo Maria Gravagnuolo
Layla Faqih
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: layla.faqih@md.catapult.org.uk mark.wigglesworth@md.catapult.org.uk
Cara Cronshaw
2Department of Health & Social Care, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jackie Wynn
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewis Burglin
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Klapper
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
3The University of Manchester, Oxford Rd, Manchester, M13 9PL, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Wigglesworth
1Medicines Discovery Catapult, Lighthouse Labs, Alderley Park, Mereside, Alderley Edge, Cheshire, SK10 4TG, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: layla.faqih@md.catapult.org.uk mark.wigglesworth@md.catapult.org.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Lighthouse Labs network tests for the presence of RNA of SARS-CoV-2, the causative agent of COVID-19. The Thermofisher TaqPath assay targets three regions of SARS-CoV-2; ORF1ab, N and S-genes. The assay identified a drop in S-gene target detection among positive samples due to the circulation of a new SARS-CoV-2 Variant of Concern (VOC) designated as 202012/01. By end of December 2020, 60% of daily positive test results at Alderley Park Lighthouse Labs, were linked to the new Variant of Concern. This timeline view identifies the rapid spread of the variant across the country.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

COVID-19 National Testing Programme - Department of Health & Social Care

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The manuscript was reviewed by the Head of Approvals Support, NHS Health Research Authority (HRA-NHS, UK), who confirmed that the study which used unlinked and anonymised data was health surveillance and did not require NHS Research ethics review (letter available upon request)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Full data available upon formal request addressed to the corresponding author Layla Faqih for auditing purposes

https://lighthouselabsalderleypark.org.uk/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England
Alfredo Maria Gravagnuolo, Layla Faqih, Cara Cronshaw, Jackie Wynn, Lewis Burglin, Paul Klapper, Mark Wigglesworth
medRxiv 2021.01.14.21249386; doi: https://doi.org/10.1101/2021.01.14.21249386
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Epidemiological Investigation of New SARS-CoV-2 Variant of Concern 202012/01 in England
Alfredo Maria Gravagnuolo, Layla Faqih, Cara Cronshaw, Jackie Wynn, Lewis Burglin, Paul Klapper, Mark Wigglesworth
medRxiv 2021.01.14.21249386; doi: https://doi.org/10.1101/2021.01.14.21249386

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1099)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (502)
  • Epidemiology (9781)
  • Forensic Medicine (5)
  • Gastroenterology (481)
  • Genetic and Genomic Medicine (2317)
  • Geriatric Medicine (223)
  • Health Economics (462)
  • Health Informatics (1563)
  • Health Policy (737)
  • Health Systems and Quality Improvement (606)
  • Hematology (238)
  • HIV/AIDS (506)
  • Infectious Diseases (except HIV/AIDS) (11655)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (239)
  • Medical Ethics (67)
  • Nephrology (258)
  • Neurology (2146)
  • Nursing (134)
  • Nutrition (338)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (518)
  • Oncology (1183)
  • Ophthalmology (365)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (147)
  • Palliative Medicine (50)
  • Pathology (312)
  • Pediatrics (698)
  • Pharmacology and Therapeutics (302)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2187)
  • Public and Global Health (4672)
  • Radiology and Imaging (781)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (624)
  • Rheumatology (274)
  • Sexual and Reproductive Health (226)
  • Sports Medicine (210)
  • Surgery (252)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)